Pediatrics
Melania Bembea, MD, MPH, PhD
Johns Hopkins University, Maryland
Disclosure(s): No relevant financial relationship(s) to disclose.
Erin Barreto, MSc, PharmD, FCCM (she/her/hers)
Mayo Clinic, Minnesota
Disclosure information not submitted.
Extracorporeal membrane oxygenation (ECMO) has been a lifesaving support for critically ill pediatric patients for more than 50 years, but complications are frequent, life-altering, and often fatal. Serious neurologic injury, bleeding, and thrombotic complications are more common in children than in ECMO-supported adults, and we are only beginning to recognize and address these disparities in outcomes. This session will describe key community-wide initiatives, including the SCCM-endorsed Core Elements Needed for Trials, Regulation, and Quality of Life (ECMO-CENTRAL) definitions of adverse events to identify short- and long-term epidemiology of ECMO consequences during critical illness, as well as strategies to improve the outcomes of children on ECMO. This session will be patient-centered and multiprofessional and will address pathophysiology, the evidence to date, impact on patients and families, and ECMO technology.
Kim Rodriguez, N/A (she/her/hers)
Peta Alexander, MBBS, FRACP, FCICM – Boston Children's Hospital
Owen J. McCarty, PhD (he/him/his)
Ryan Barbaro, MD, MS – University of Michigan Health System